|
CN109248177A
|
|
The preparation of crocodile first active principle and its anti-oxidant, anti-hepatic fibrosis application
|
|
CN109295042A
|
|
A kind of preparation method and applications of natural Sipunculus nudus plasmin
|
|
CN109265553A
|
|
A kind of fusion protein of cytoglobin and Sipunculus nudus plasmin
|
|
CN104873987A
|
|
Preparation and application of targeting liver cancer gene therapeutic drug scrAAV-Kal
|
|
CN104826134A
|
|
Anti-hepatic fibrosis gene drug rAAV8-KAL
|
|
CN104800244A
|
|
Crocodile shell extract for treating hepatic fibrosis and application of crocodile shell extract
|
|
CN104815338A
|
|
KAL (Kallistating) genetic recombination gland related virus vector carried gene therapy drug
|
|
CN104232687A
|
|
Separation and purification method for rAAV (recombinant adeno-associated virus) vector
|
|
CN104873958A
|
|
Application of recombinant and syncretic Tat-Cygb protein in anti-hepatic fibrosis
|
|
CN103336127A
|
|
Indicator and diagnostic agent of early-stage hepatopathy, hepatic fibrosis and hepatic cirrhosis
|
|
CN103333875A
|
|
Marine phasolosma esculenta fibrinolytic enzyme, preparation method and applications thereof
|
|
CN103382463A
|
|
Ocean Sipunculus nudus plasmin and its preparation and application
|
|
CN103145833A
|
|
Urechis unicinctus hemoglobin, isolation and purification thereof and application
|
|
CN103114152A
|
|
Quantitative PCR method for measuring recombinant adeno-associated virus titer
|
|
CN101863985A
|
|
Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer
|
|
CN102266355B
|
|
Crocodile scale extract and application thereof
|
|
CN1966082A
|
|
Genetic medicine for preventing and treating cancer of colon and rectum, preparation process and use thereof
|
|
US2006153809A1
|
|
Recombinant trail vectors and uses thereof
|
